
### [Orphanet:98274](http://www.orpha.net/ORDO/Orphanet_98274)
**Label:** Myeloproliferative neoplasm

**Subclasses:** [Orphanet:86830](http://www.orpha.net/ORDO/Orphanet_86830) (Chronic myeloproliferative disease, unclassifiable), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318) (Essential thrombocythemia), [Orphanet:729](http://www.orpha.net/ORDO/Orphanet_729) (Polycythemia vera), [Orphanet:420611](http://www.orpha.net/ORDO/Orphanet_420611) (Transient myeloproliferative syndrome), [Orphanet:824](http://www.orpha.net/ORDO/Orphanet_824) (Primary myelofibrosis), [Orphanet:480851](http://www.orpha.net/ORDO/Orphanet_480851) (Hereditary thrombocytopenia with early-onset myelofibrosis), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521) (Chronic myeloid leukemia), 

**Corr. equiv. classes:** [OMIM:159595](http://purl.obolibrary.org/obo/OMIM_159595), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [OMIM:263300](http://purl.obolibrary.org/obo/OMIM_263300), [OMIM:131440](http://purl.obolibrary.org/obo/OMIM_131440), [Orphanet:86830](http://www.orpha.net/ORDO/Orphanet_86830), [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [OMIM:254450](http://purl.obolibrary.org/obo/OMIM_254450), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318), [Orphanet:420611](http://www.orpha.net/ORDO/Orphanet_420611), [Orphanet:729](http://www.orpha.net/ORDO/Orphanet_729), [OMIM:616937](http://purl.obolibrary.org/obo/OMIM_616937), [Orphanet:824](http://www.orpha.net/ORDO/Orphanet_824), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), [Orphanet:480851](http://www.orpha.net/ORDO/Orphanet_480851), 

**Class expressions from DL-Learner:**

- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) 57.88%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 41.44%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 39.51%
- Thing 39.50%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 39.50%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 39.38%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 37.55%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 32.10%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 30.57%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 30.29%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 23.85%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 18.00%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 14.66%


